INSM
Income statement / Annual
Last year (2023), Insmed Incorporated's total revenue was $305.21 M,
an increase of 24.39% from the previous year.
In 2023, Insmed Incorporated's net income was -$749.57 M.
See Insmed Incorporated’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$305.21 M
|
$245.36 M
|
$188.46 M
|
$164.41 M
|
$136.47 M
|
$9.84 M
|
$0.00
|
$0.00
|
$0.00
|
$11.50 M
|
| Cost of Revenue |
$65.57 M |
$55.13 M |
$44.15 M |
$39.87 M |
$24.21 M |
$2.42 M |
$2.90 M |
$2.44 M |
$1.98 M |
$33.53 M |
| Gross Profit |
$239.64 M |
$190.23 M |
$144.31 M |
$124.54 M |
$112.26 M |
$7.41 M |
-$2.90 M |
-$2.44 M |
-$1.98 M |
-$22.03 M |
| Gross Profit Ratio |
0.79 |
0.78 |
0.77 |
0.76 |
0.82 |
0.75 |
0 |
0 |
0 |
-1.92 |
| Research and Development
Expenses |
$571.01 M
|
$397.52 M
|
$272.74 M
|
$181.16 M
|
$131.71 M
|
$145.28 M
|
$109.75 M
|
$122.72 M
|
$74.28 M
|
$56.29 M
|
| General & Administrative
Expenses |
$344.50 M
|
$244.98 M
|
$234.27 M
|
$203.61 M
|
$210.80 M
|
$168.22 M
|
$79.17 M
|
$50.68 M
|
$43.22 M
|
$31.07 M
|
| Selling & Marketing
Expenses |
$0.00
|
$20.80 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$344.50 M
|
$265.78 M
|
$234.27 M
|
$203.61 M
|
$210.80 M
|
$168.22 M
|
$79.17 M
|
$50.68 M
|
$43.22 M
|
$31.07 M
|
| Other Expenses |
$33.75 M |
$5.05 M |
$5.05 M |
$5.00 M |
$4.99 M |
$602,000.00 |
$300,000.00 |
$119,000.00 |
-$33,000.00 |
$141,000.00 |
| Operating Expenses |
$949.26 M |
$668.36 M |
$512.07 M |
$389.77 M |
$347.50 M |
$314.75 M |
$188.92 M |
$173.40 M |
$117.49 M |
$87.37 M |
| Cost And Expenses |
$1.01 B |
$723.48 M |
$556.22 M |
$429.65 M |
$371.71 M |
$317.17 M |
$188.92 M |
$173.40 M |
$117.49 M |
$87.37 M |
| Interest Income |
$39.24 M |
$11.08 M |
$174,000.00 |
$1.70 M |
$9.92 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$0.00 |
$26.45 M |
$40.47 M |
$29.56 M |
$27.71 M |
$25.47 M |
$5.93 M |
$3.50 M |
$2.89 M |
$2.42 M |
| Depreciation &
Amortization |
$10.58 M
|
$24.27 M
|
$27.85 M
|
$20.08 M
|
$10.18 M
|
$4.83 M
|
$2.90 M
|
$2.44 M
|
$1.98 M
|
$1.07 M
|
| EBITDA |
-$654.74 M
|
-$429.44 M
|
-$375.09 M
|
-$250.37 M
|
-$215.67 M
|
-$293.78 M
|
-$184.10 M
|
-$170.24 M
|
-$115.28 M
|
-$86.09 M
|
| EBITDA Ratio |
-2.15 |
-1.87 |
-1.98 |
-1.58 |
-1.69 |
-31.06 |
0 |
0 |
0 |
-7.58 |
| Operating Income Ratio
|
-2.33
|
-1.95
|
-1.95
|
-1.61
|
-1.72
|
-31.25
|
0
|
0
|
0
|
-7.6
|
| Total Other
Income/Expenses Net |
-$37.39 M
|
-$2.03 M
|
-$61.32 M
|
-$27.46 M
|
-$18.32 M
|
-$16.74 M
|
-$4.00 M
|
-$2.78 M
|
-$2.66 M
|
-$2.22 M
|
| Income Before Tax |
-$747.01 M |
-$480.15 M |
-$436.41 M |
-$292.69 M |
-$253.56 M |
-$324.08 M |
-$192.92 M |
-$176.18 M |
-$120.15 M |
-$89.58 M |
| Income Before Tax Ratio
|
-2.45
|
-1.96
|
-2.32
|
-1.78
|
-1.86
|
-32.95
|
0
|
0
|
0
|
-7.79
|
| Income Tax Expense |
$2.56 M |
$1.38 M |
-$1.76 M |
$1.40 M |
$777,000.00 |
$201,000.00 |
-$272,000.00 |
$98,000.00 |
-$1.97 M |
-$10.42 M |
| Net Income |
-$749.57 M |
-$481.53 M |
-$434.65 M |
-$294.09 M |
-$254.34 M |
-$324.28 M |
-$192.65 M |
-$176.27 M |
-$118.18 M |
-$79.16 M |
| Net Income Ratio |
-2.46 |
-1.96 |
-2.31 |
-1.79 |
-1.86 |
-32.97 |
0 |
0 |
0 |
-6.88 |
| EPS |
-5.34 |
-3.91 |
-3.88 |
-3.01 |
-3.01 |
-4.22 |
-2.89 |
-2.85 |
-2.02 |
-1.84 |
| EPS Diluted |
-5.34 |
-3.91 |
-3.88 |
-3.01 |
-3.01 |
-4.22 |
-2.89 |
-2.85 |
-2.02 |
-1.84 |
| Weighted Average Shares
Out |
$140.43 M
|
$123.04 M
|
$112.11 M
|
$97.61 M
|
$84.56 M
|
$76.84 M
|
$66.58 M
|
$61.85 M
|
$58.51 M
|
$43.02 M
|
| Weighted Average Shares
Out Diluted |
$140.43 M
|
$123.04 M
|
$112.11 M
|
$97.61 M
|
$84.56 M
|
$76.89 M
|
$66.58 M
|
$61.89 M
|
$58.63 M
|
$43.10 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
